JO
BLTE

John Overdeck’s Belite Bio BLTE Stock Holding History

John Overdeck’s Portfolio BLTE Stock Details BLTE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.87M Buy
+38,100
New +$5.84M ﹤0.01% 1989

Other funds holding BLTE

DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

John Overdeck's BLTE Position: Q2 2026 in Review

John Overdeck opened a new position in Belite Bio (BLTE) in Q2 2026: 38,100 shares worth $5.87M. The stake represents ﹤0.01% of the portfolio and ranks #1989 among its holdings.

81 funds tracked by Wall St. Rank hold BLTE as of Q2 2026.

  • John Overdeck held 38,100 shares of Belite Bio worth $5.87M as of Q2 2026.
  • Belite Bio was a new John Overdeck position in Q2 2026.
  • Belite Bio made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #1989 holding.
  • 81 funds tracked by Wall St. Rank held Belite Bio as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.